Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Philip M.P. Poortmans"'
Autor:
Philip M.P. Poortmans, Silvia Takanen, Gustavo Nader Marta, Icro Meattini, Orit Kaidar-Person
Publikováno v:
Breast, Vol 49, Iss , Pp 194-200 (2020)
Artificial intelligence demonstrated its value for automated contouring of organs at risk and target volumes as well as for auto-planning of radiation dose distributions in terms of saving time, increasing consistency, and improving dose-volumes para
Externí odkaz:
https://doaj.org/article/787b71ffa51d40f9a78f7e49a3ee9ab7
Publikováno v:
Breast, 31, 295-302
Breast, 31, pp. 295-302
Breast, 31, pp. 295-302
Item does not contain fulltext Decreasing the burden of radiation therapy (RT) for breast cancer includes, next to complete omission, several ways to tailor the extent of RT. Possible options for this include lowering of the total dose, such as selec
Autor:
Bolla M; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt. mbolla@chu-grenoble.fr., Maingon P; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Carrie C; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Villa S; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Kitsios P; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Poortmans PM; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Sundar S; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., van der Steen-Banasik EM; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Armstrong J; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Bosset JF; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Herrera FG; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Pieters B; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Slot A; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Bahl A; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Ben-Yosef R; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Boehmer D; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Scrase C; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Renard L; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Shash E; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Coens C; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., van den Bergh AC; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt., Collette L; Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon, Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon; Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon, France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain; Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans, Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik, Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam; Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar, Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham; Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne, Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer, Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard, Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and Emad Shash, Cairo University, Cairo, Egypt.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2016 May 20; Vol. 34 (15), pp. 1748-56. Date of Electronic Publication: 2016 Mar 14.